-
FDA Wants Merck To Change Januvia Label With Increased Warning About Pancreatitis Risk
Is Januvia Similar To Byetta In Terms Of The So-Called Class Effect And Drug Injury Lawsuits Being Filed? (Posted by Tom Lamb at DrugInjuryWatch.com) On September 25, 2009 the FDA posted on its web…
-
Asthma Drug Xolair Is Being Investigated By FDA For Possible Cardiac Problems
Serious Side Effects Include Heart Attacks, Abnormal Heart Rhythms, Heart Failure, And Various Conditions Caused By Blood Clots (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE: "Xolair Is Associated With Higher Than Expected Reporting…
-
Drug-Company Sponsored Ghostwriters Are Getting Busted By Some Medical Journals
Drug Industry Document Archive (DIDA) Adds Newly Released Wyeth Ghostwriting Documents In September 2009 (Posted by Tom Lamb at DrugInjuryWatch.com) A September 18, 2009 article, "Medical Editors Push for Crackdown on Ghostwriting", published by…
-
Some Of The Drospirenone (DRSP) Progestin Used In Yaz And Yasmin Pills May Have Been Of Bad Quality
August 2009 FDA Warning Letter Sent To Bayer Relates To Quality Control Problems Found In March 2009 At German Facility Where DRSP Was Made (Posted by Tom Lamb at DrugInjuryWatch.com) By means of a…
-
September 2009 Update On Paxil Lawsuits Alleging Birth Defects
Reports About Paxil Cases In Boston, Philadelphia, And Mississippi (Posted by Tom Lamb at DrugInjuryWatch.com) To set the stage we start back in December 2005, when the FDA issued a News Release titled "FDA…